Trademarkia Logo

Canada

C$
Trademark Search in Canada
NEUROCRINE BIOSCIENCES

View On IC.GC.CA

NEUROCRINE BIOSCIENCES
REGISTERED

on 17 Jan 2025

Last Applicant/ Owned by

Neurocrine Biosciences, Inc.

12780 El Camino RealSan Diego CA 92130

US

Serial Number

2176289 filed on 26th Jan 2022

Registration Number

TMA1284404 registered on 17th Jan 2025

Registration expiry Date

26th Jan 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

NEUROCRINE BIOSCIENCES

Trademark usage description

pharmaceutical preparations for human use for the treatment of huntington's disease, chorea associated with huntington's disease, schizophrenia, adjun Read More

Vienna Information

1 . 15 . 23

Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).Tourbillons, mouvements rotatifs, tornade -- Note: Non compris les orbites astronomiques (1.13.1), les orbites atomiques (1.13.1), les cercles concentriques (26.1.4 ou 26.1.5) et les spirales (26.1.5).

16 . 3 . 1

Photographic or cinematographic apparatus, projection apparatus and lanterns -- Note: Including video cameras, traffic radars and photographic lenses.Appareils photographiques ou cinématographiques, appareils et lanternes de projection -- Note: Y compris les caméras vidéo, les radars routiers et les objectifs photographiques.

16 . 3 . 3

Iris diaphragmsDiaphragmes en forme d'iris

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro immunological and neuroendocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, Major Depressive Disorder, cognitive disorders, schizophrenia, and psychoses, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, Parkinson's disease, GBA1-mediated diseases, central nervous system [CNS] diseases, hormonal disorders, genetic disorders and movement diseases, disorders and conditions, tardive dyskinesia, dystonia, tics, Tourette syndrome; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

Classification kind code

11

Class [042]
Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions.

Classification kind code

11

Class [044]
Providing medical information namely, information, advisory and consultancy services in the field of gene therapy; providing medical information in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions

Classification kind code

11

Mark Details

Serial Number

2176289

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 13th Jul 2023		Search Recorded
Submitted for opposition 20
on 13th Jul 2023		Examiner's First Report
Submitted for opposition 223
on 13th Jul 2023		Total Provisional Refusal
Submitted for opposition 256
on 31st Jan 2023		Notification of Possible Opposition Sent
Submitted for opposition 48
on 15th Jun 2022		Agent Changed
Submitted for opposition 257
on 31st Mar 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 30th Mar 2022		Formalized
Submitted for opposition 1
on 30th Mar 2022		Created
Submitted for opposition 228
on 26th Jan 2022		International Registration
Submitted for opposition 30
on 26th Jan 2022		Filed